These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 16403)
1. [Effect of cardiovascular drugs on electrolyte metabolism (review of the literature)]. Samilova RD Vrach Delo; 1977 Feb; (2):37-45. PubMed ID: 16403 [No Abstract] [Full Text] [Related]
2. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart]. Fratz R; Greeff K; Wagner J Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000 [No Abstract] [Full Text] [Related]
3. [Metabolism of magnesium and its role in the mechanism of action of cardiovascular agents (review of the literature)]. Chekman IS; Gorchakova NA; Tkachuk VV Farmakol Toksikol; 1981; 44(6):743-8. PubMed ID: 7030779 [No Abstract] [Full Text] [Related]
4. [Basis of the active mechanism of cardioactive glycoside]. Schoner W Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():6-18. PubMed ID: 148185 [No Abstract] [Full Text] [Related]
5. [Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria]. Reuter N; Heeg E Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):323-33. PubMed ID: 4402232 [No Abstract] [Full Text] [Related]
6. [Progress in the field of drug development. 6]. Koch H; Mayr E; Richter J; Selchau M Pharmazie; 1973; 28(11):691-713. PubMed ID: 4151594 [No Abstract] [Full Text] [Related]
7. [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides]. Kukes VG; Volkov RIu Kardiologiia; 1977 Sep; 17(9):135-42. PubMed ID: 144820 [No Abstract] [Full Text] [Related]
9. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1). Graeff DM; Johnson WE; Martin AR Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737 [No Abstract] [Full Text] [Related]
10. Interaction between potassium concentration and inhibition of myocardial Na(+)-K(+)-ATPase by two class 1A antiarrhythmic drugs: quinidine and procainamide. Dzimiri N; Almotrefi AA Arch Int Pharmacodyn Ther; 1991; 314():34-43. PubMed ID: 1668603 [TBL] [Abstract][Full Text] [Related]
11. The effects of pharmacologic agents on myocardial sodium (Na+) and potassium (K+) stimulated ATPase. Song SY; Scheuer J Pharmacology; 1968; 1(4):209-17. PubMed ID: 4236484 [No Abstract] [Full Text] [Related]
16. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol. Castellucci A Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206 [TBL] [Abstract][Full Text] [Related]
17. A-V conduction disturbance: its pathophysiology and pharmacology. Watanabe Y Singapore Med J; 1973 Sep; 14(3):249. PubMed ID: 4777868 [No Abstract] [Full Text] [Related]
18. [Current antihypertensive drugs: mechanism of action]. Perrier CV; Sitavanc L Schweiz Med Wochenschr; 1973 Nov; 103(47):1678-86. PubMed ID: 4150373 [No Abstract] [Full Text] [Related]
19. Effects of etafenone and antiarrhythmic drugs on Na and Ca channels of guinea pig atrial muscle. Hashimoto K; Satoh H; Imai S J Cardiovasc Pharmacol; 1979; 1(5):561-70. PubMed ID: 94412 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive agents. Wilhelm M; DeStevens G Prog Drug Res; 1976; 20():197-259. PubMed ID: 13458 [No Abstract] [Full Text] [Related] [Next] [New Search]